{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:07:12Z","timestamp":1791493632302,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007067","name":"Kempestiftelserna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jbc.2024.108031","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T23:50:52Z","timestamp":1732837852000},"page":"108031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Misfolding of transthyretin in\u00a0vivo is controlled by the redox environment and macromolecular crowding"],"prefix":"10.1016","volume":"301","author":[{"given":"Sanduni Wasana","family":"Jayaweera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0588-600X","authenticated-orcid":false,"given":"Melisnur","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7281-8284","authenticated-orcid":false,"given":"Fabian","family":"Lundkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Leven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tereenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"B\u00e4ckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3137-9266","authenticated-orcid":false,"given":"Anushree","family":"Bachhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0634-7091","authenticated-orcid":false,"given":"Fouzia","family":"Bano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intissar","family":"Anan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.108031_bib1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plante-Bordeneuve","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jbc.2024.108031_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1750-1172-9-61","article-title":"THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease","volume":"9","author":"Wixner","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jbc.2024.108031_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10286-019-00628-6","article-title":"Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis","volume":"29","author":"Obici","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.jbc.2024.108031_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human transthyretin (TTR) variants, 2003","volume":"10","author":"Connors","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2024.108031_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14797\/mdcvj.1066","article-title":"ATTR epidemiology, genetics, and prognostic factors","volume":"18","author":"Obi","year":"2022","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"10.1016\/j.jbc.2024.108031_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13023-023-02910-3","article-title":"Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal","volume":"18","author":"Ando","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jbc.2024.108031_bib7","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","article-title":"Fibril in senile systemic amyloidosis is derived from normal transthyretin","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108031_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.jbc.2024.108031_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1827.1995.tb03373.x","article-title":"Genetic abnormalities and pathogenesis of familial amyloidotic polyneuropathy","volume":"45","author":"Murakami","year":"1995","journal-title":"Pathol. Int."},{"key":"10.1016\/j.jbc.2024.108031_bib10","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/S0021-9258(18)93118-2","article-title":"The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex","volume":"244","author":"Raz","year":"1969","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.108031_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-3233(08)60321-6","article-title":"Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid","volume":"50","author":"Kelly","year":"1997","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.jbc.2024.108031_bib12","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.93.26.15051","article-title":"Inhibiting transthyretin amyloid fibril formation via protein stabilization","volume":"93","author":"Miroy","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108031_bib13","doi-asserted-by":"crossref","first-page":"13527","DOI":"10.1021\/bi00041a032","article-title":"Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease","volume":"34","author":"McCutchen","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.108031_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.108031_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2023.4147","article-title":"Effect of Tafamidis on cardiac function in patients with transthyretin amyloid cardiomyopathy: a post Hoc analysis of the ATTR-ACT randomized clinical trial","volume":"9","author":"Shah","year":"2024","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.jbc.2024.108031_bib16","first-page":"93","article-title":"New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experience","volume":"2","author":"Suhr","year":"2012","journal-title":"Degener Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.jbc.2024.108031_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2024.108031_bib18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2024.108031_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016072118","article-title":"A\u00a0circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction","volume":"118","author":"Jiang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108031_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/j.1460-2075.1993.tb05707.x","article-title":"Structure of Met30 variant of transthyretin and its amyloidogenic implications","volume":"12","author":"Terry","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.108031_bib21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/j.1460-2075.1993.tb05708.x","article-title":"Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation","volume":"12","author":"Thylen","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.108031_bib22","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/febs.17070","article-title":"Trypsin-induced aggregation of transthyretin Valine 30 variants associated with hereditary amyloidosis","volume":"291","author":"Mizuguchi","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2024.108031_bib23","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1038\/s41467-021-27416-z","article-title":"Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis","volume":"12","author":"Slamova","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108031_bib24","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.RA118.003990","article-title":"Plasminogen activation triggers transthyretin amyloidogenesis in\u00a0vitro","volume":"293","author":"Mangione","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.108031_bib25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1073\/pnas.1317488111","article-title":"Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis","volume":"111","author":"Mangione","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108031_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cca.2019.08.034","article-title":"The presence of S-sulfonated transthyretin in commercial human serum albumin solutions: potential contribution to neuropathy","volume":"499","author":"Rael","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jbc.2024.108031_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2017.04.015","article-title":"Cysteinylated transthyretin as a discriminator of cardiovascular risk in patients with diabetes mellitus","volume":"470","author":"Wakabayashi","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jbc.2024.108031_bib28","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bbapap.2010.03.010","article-title":"S-sulfonation of transthyretin is an important trigger step in the formation of transthyretin-related amyloid fibril","volume":"1804","author":"Nakanishi","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2024.108031_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9440(10)63123-9","article-title":"Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met","volume":"164","author":"Takaoka","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jbc.2024.108031_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/bbrc.1998.9097","article-title":"Post-translational modification of transthyretin in plasma","volume":"249","author":"Terazaki","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2024.108031_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102390","article-title":"Global approaches for protein thiol redox state detection","volume":"77","author":"Knoke","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.108031_bib32","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1073\/pnas.96.6.3108","article-title":"Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants","volume":"96","author":"Goldsteins","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108031_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/j.1460-2075.1993.tb05707.x","article-title":"Structure of Met30 variant of transthyretin and its amyloidogenic implications","volume":"12","author":"disTerry","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.108031_bib34","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1742-4658.2009.06936.x","article-title":"Stability and fibril formation properties of human and fish transthyretin, and of the Escherichia coli transthyretin-related protein","volume":"276","author":"Lundberg","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2024.108031_bib35","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1074\/jbc.M310605200","article-title":"Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy","volume":"279","author":"Olofsson","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.108031_bib36","doi-asserted-by":"crossref","first-page":"11887","DOI":"10.1074\/jbc.M709638200","article-title":"The modulation of transthyretin tetramer stability by cysteine 10 adducts and the drug diflunisal. Direct analysis by fluorescence-detected analytical ultracentrifugation","volume":"283","author":"Kingsbury","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.108031_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbapap.2003.10.005","article-title":"Modification of cysteine residue in transthyretin and a synthetic peptide: analyses by electrospray ionization mass spectrometry","volume":"1698","author":"Nakanishi","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2024.108031_bib38","first-page":"976","article-title":"Transthyretin familial amyloid polyneuropathy: an update","volume":"265","author":"Plante-Bordeneuve","year":"2018","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jbc.2024.108031_bib39","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1038\/s41467-023-43301-3","article-title":"Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis","volume":"14","author":"Steinebrei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108031_bib40","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108031_bib41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1006\/jmbi.2000.4078","article-title":"A\u00a0comparative analysis of 23 structures of the amyloidogenic protein transthyretin","volume":"302","author":"Hornberg","year":"2000","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.108031_bib42","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15252\/emmm.201505357","article-title":"A\u00a0novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis","volume":"7","author":"Marcoux","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jbc.2024.108031_bib43","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbrc.2008.10.121","article-title":"Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture","volume":"377","author":"Sorgjerd","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2024.108031_bib44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/13506120802524916","article-title":"Formation of cytotoxic transthyretin is not dependent on inter-molecular disulphide bridges commonly found within the amyloid form","volume":"15","author":"Lindhagen-Persson","year":"2008","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2024.108031_bib45","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.0400062101","article-title":"Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture","volume":"101","author":"Reixach","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108031_bib46","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/cphc.201800534","article-title":"Non-steric interactions predict the trend and steric interactions the offset of protein stability in cells","volume":"19","author":"Davis","year":"2018","journal-title":"Chemphyschem"},{"key":"10.1016\/j.jbc.2024.108031_bib47","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1016\/S0021-9258(18)77236-0","article-title":"\"Macromolecular crowding\": thermodynamic consequences for protein-protein interactions within the T4 DNA replication complex","volume":"265","author":"Jarvis","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.108031_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1748-1716.1977.tb10345.x","article-title":"Protein concentration in interstitial and lymphatic fluids from the subcutaneous tissue","volume":"99","author":"Rutili","year":"1977","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.jbc.2024.108031_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000265422","article-title":"Relation of vitreous amyloidosis to prealbumin","volume":"18","author":"Sandgren","year":"1986","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jbc.2024.108031_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/13506129.2023.2167595","article-title":"Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid","volume":"30","author":"Tsai","year":"2023","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2024.108031_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00401-022-02501-9","article-title":"Neuropathology of central nervous system involvement in TTR amyloidosis","volume":"145","author":"Taipa","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2024.108031_bib52","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1021\/bi050378f","article-title":"Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S\/V30M transgenic mice?","volume":"44","author":"Zhang","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.108031_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-3083.1991.tb01521.x","article-title":"Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111","volume":"34","author":"Magnus","year":"1991","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jbc.2024.108031_bib54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ajpath.2018.09.015","article-title":"The accumulation of heparan sulfate S-domains in kidney transthyretin deposits accelerates fibril formation and promotes cytotoxicity","volume":"189","author":"Kameyama","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jbc.2024.108031_bib55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jb\/mvu039","article-title":"Macromolecular crowding decelerates aggregation of a beta-rich protein, bovine carbonic anhydrase: a case study","volume":"156","author":"Mittal","year":"2014","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.jbc.2024.108031_bib56","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.1021\/bi8008399","article-title":"Guiding protein aggregation with macromolecular crowding","volume":"47","author":"Munishkina","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.108031_bib57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00249-020-01486-1","article-title":"Molecular crowding accelerates aggregation of alpha-synuclein by altering its folding pathway","volume":"50","author":"Biswas","year":"2021","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.jbc.2024.108031_bib58","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1021\/bi0120906","article-title":"Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease?","volume":"41","author":"Shtilerman","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.108031_bib59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(02)02446-8","article-title":"Accelerated alpha-synuclein fibrillation in crowded milieu","volume":"515","author":"Uversky","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2024.108031_bib60","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.3390\/molecules28186555","article-title":"Fibrillization process of human amyloid-beta protein (1-40) under a molecular crowding environment mimicking the interior of living cells using cell debris","volume":"28","author":"Hirai","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2024.108031_bib61","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.bbapap.2016.07.012","article-title":"Macromolecular crowding favors the fibrillization of beta2-microglobulin by accelerating the nucleation step and inhibiting fibril disassembly","volume":"1864","author":"Luo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2024.108031_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13510002.2022.2046423","article-title":"Role of mitochondrial reactive oxygen species in homeostasis regulation","volume":"27","author":"Zhang","year":"2022","journal-title":"Redox Rep."},{"key":"10.1016\/j.jbc.2024.108031_bib63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2024.108031_bib64","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/00207454.2012.711400","article-title":"Analysis of mitochondrial haplogroups associated with TTR Val30Ala familial amyloidotic polyneuropathy in Chinese patients","volume":"122","author":"Liu","year":"2012","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jbc.2024.108031_bib65","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/ejhg.2010.36","article-title":"TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?","volume":"18","author":"Bonaiti","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jbc.2024.108031_bib66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0004.2008.01097.x","article-title":"Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients","volume":"75","author":"Olsson","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jbc.2024.108031_bib67","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1006\/bbrc.1996.5997","article-title":"Oxidative stress is found in amyloid deposits in systemic amyloidosis","volume":"232","author":"Ando","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2024.108031_bib68","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3390\/jpm12050792","article-title":"Transthyretin amyloid cardiomyopathy: impact of transthyretin amyloid deposition in myocardium on cardiac morphology and function","volume":"12","author":"Nakano","year":"2022","journal-title":"J.\u00a0Pers Med."},{"key":"10.1016\/j.jbc.2024.108031_bib69","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.phrs.2010.08.001","article-title":"Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model","volume":"62","author":"Macedo","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jbc.2024.108031_bib70","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri3423","article-title":"Beyond oxidative stress: an immunologist's guide to reactive oxygen species","volume":"13","author":"Nathan","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2024.108031_bib71","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1021\/pr4001948","article-title":"Partition and turnover of glutathione reductase from Saccharomyces cerevisiae: a proteomic approach","volume":"12","author":"Couto","year":"2013","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.jbc.2024.108031_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.ircmb.2022.08.001","article-title":"Targeting amino acid metabolism in cancer","volume":"373","author":"Safrhansova","year":"2022","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.jbc.2024.108031_bib73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.22540\/JFSF-07-032","article-title":"B12 levels and frailty syndrome","volume":"7","author":"Pyrgioti","year":"2022","journal-title":"J.\u00a0Frailty Sarcopenia Falls"},{"key":"10.1016\/j.jbc.2024.108031_bib74","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/antiox12071316","article-title":"N-Acetylcysteine pharmacology and applications in rare diseases-repurposing an old antioxidant","volume":"12","author":"Sahasrabudhe","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jbc.2024.108031_bib75","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1089\/ars.2012.5125","article-title":"Does N-acetylcysteine modulate post-translational modifications of transthyretin in hemodialysis patients?","volume":"19","author":"Henze","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.jbc.2024.108031_bib76","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/antiox12091736","article-title":"The reactive species interactome in red blood cells: oxidants, antioxidants, and molecular targets","volume":"12","author":"Cortese-Krott","year":"2023","journal-title":"Antioxidants (Basel)"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582402533X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582402533X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T21:14:35Z","timestamp":1738012475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582402533X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S002192582402533X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.108031","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Misfolding of transthyretin in\u00a0vivo is controlled by the redox environment and macromolecular crowding","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.108031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"108031"}}